ACTIVE

THERACELL ADVANCED BIOTECHNOLOGY (Belgium)

Export PDF

Financial year 2022 · Closed on 31/12/2022

Net result-128,3 k €-91,9 %over 1 year
Gross margin-37,2 k €-272,8 %over 1 year
Equity-179,1 k €-252,8 %over 1 year

Identity

Source · BCE/KBO

THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is a Private limited company incorporated in 2019. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Marche-en-Famenne.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0731.712.273
Incorporation
30/07/2019
Legal form
Private limited company
Registered office
Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2022
Joint committees (1)
  • 207
Contacts
1 public detail availableLog in to view
Signals
Good liquidityHealthy social debts

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202220212020
Income statement
Gross margin-37,2 k €-10 k €-1,8 k €
EBITDA-127,4 k €-66,2 k €-2,5 k €
Operating result-127,4 k €-66,2 k €-2,5 k €
Net result-128,3 k €-66,9 k €-2,5 k €
Balance sheet
Equity-179,1 k €-50,8 k €16,1 k €
Total assets327,8 k €456,9 k €216,1 k €
Cash206,6 k €455,8 k €215,9 k €
Debts506,9 k €507,6 k €200 k €

Board of directors

Source · NBB, accounts to 31/12/2022

1 active

Active mandates

DirectorMandates in this companyPeriod
Fotios Sakellaridis
Director

Other companies at this address

Aye, Rue de la Science 8 6900 Marche-en-Famenne
CompanyCBE no.
AGRICELLS● Active
0742.991.393
ALEXEIA● Active
1043.223.221
Association pour le développement des Productions Agroalimentaires de qualité● Active
0416.914.413
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne● Active
0457.901.762
ASSOCIATION POUR L'USAGE ET LA DEFENSE DU SAUCISSON D'ARDENNE● Active
0863.356.814
ATB THERAPEUTICS● Active
0677.980.015
Bureau d’Administration ATB THERAPEUTICS● Active
1031.100.991
CER-Groupe● Active
0420.654.158
INVESTY CORPORATE● Active
1008.960.841
LivingMed Biotech● Active
0748.443.684
Orgenesis (Belgium)● Bankrupt
0540.866.555
ORGENESIS SERVICES SRL● Bankrupt
0790.353.624
RevaTis● Active
0541.682.642
REVATIS VET● Active
1015.868.627

Full financial information

Source · NBB
202220212020
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202201/01/202129/07/2019
Closing of the financial year31/12/202231/12/202131/12/2020
Length of the financial year12 months12 months18 months
Filing date14/07/202322/08/202230/09/2021
General meeting02/05/202302/05/202203/05/2021
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202202/05/202314/07/2023FrenchPDF
Micro model31/12/202102/05/202222/08/2022FrenchPDF
Micro model31/12/202003/05/202130/09/2021FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2022

1 active

Active mandates

DirectorMandates in this companyPeriod
Fotios Sakellaridis
Director

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office18/04/2023
    Changement de siège social
    PDF
  • Other01/08/2019
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings3 filings
Mandates
Fotios Sakellaridis
20192020202120222023202420252026
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)
Avenue du Parc Industriel 89, 4041 Vottem
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Aye, Rue de la Science 8, 6900 Marche-en-FamenneCurrent
CBE
Avenue du Parc Industriel 89, 4041 Vottem
accounts 2021 → 2022
Accounts 2022 · 2023-00235065

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)Current
accounts 2020 → 2022
Accounts 2022 · 2023-00235065

Events

  1. 2022
    Annual accounts 2022-128,3 k €↓
  2. 2021
    Annual accounts 2021-66,9 k €↓
  3. 2020
    Annual accounts 2020-2,5 k €
  4. 30/07/2019
    IncorporationPrivate limited company